Kidney Function, ACE-Inhibitor/Angiotensin Receptor Blocker Use, and Survival Following Hospitalization for Heart Failure: A Cohort Study

BACKGROUND: Angiotensin-converting enzyme inhibitors/angiotensin receptor blocker (ACE-I/ARB) improve outcomes in patients with heart failure and reduced left-ventricular (LV) systolic function. However, these medications can cause a rise in serum creatinine and their benefits in patients with HF ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Michael H., Miller, Robert J. H., Barry, Rebecca, Li, Bing, Har, Bryan J., Wilton, Stephen B., Knudtson, Merril, Howlett, Jonathan G., James, Matthew T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194922/
https://www.ncbi.nlm.nih.gov/pubmed/30349729
http://dx.doi.org/10.1177/2054358118804838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194922/
https://www.ncbi.nlm.nih.gov/pubmed/30349729
http://dx.doi.org/10.1177/2054358118804838

Ejemplares similares